INTERNATIONAL PATENT: ASTRAZENECA AB FILES APPLICATION FOR "COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF MICROVASCULAR ANGINA"

GENEVA, July 2 -- ASTRAZENECA AB (SE-151-85Sodertalje) filed a patent application (PCT/IB2024/062763) for "COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF MICROVASCULAR ANGINA" on Dec 17, 2024. With publication no. WO/2025/133907, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AMBERY, Philip (ASTRAZENECA ABSE-151-85 Sodertalje), GREASLEY, Peter (ASTRAZENECA ABSE-151-85 Sodertalje)

Abstract: Methods for treating microvascular angina in patients by the use of a combination of zibotentan and dapagliflozi...